Cargando…

Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma

BACKGROUND: The molecular biology of renal cell carcinoma (RCC) is complex and not fully understood. We have recently found that the expression of the receptor tyrosine kinase Axl in the RCC tumors independently correlates with survival of the patients. PRINCIPAL FINDINGS: Here, we have investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gustafsson, Anna, Boström, Anna-Karin, Ljungberg, Börje, Axelson, Håkan, Dahlbäck, Björn
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766033/ https://www.ncbi.nlm.nih.gov/pubmed/19888345 http://dx.doi.org/10.1371/journal.pone.0007575

Ejemplares similares

The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels
por: Fritz, Helena K., et al.
Publicado: (2015)

The Notch and TGF-β Signaling Pathways Contribute to the Aggressiveness of Clear Cell Renal Cell Carcinoma
por: Sjölund, Jonas, et al.
Publicado: (2011)

Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes
por: Ekman, Carl, et al.
Publicado: (2010)

Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma
por: de Alwis, Roger, et al.
Publicado: (2023)

Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus
por: Ekman, Carl, et al.
Publicado: (2011)

Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma
por: Yu, H, et al.
Publicado: (2015)

Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma
por: Sitaram, Raviprakash T., et al.
Publicado: (2016)

The Receptor Tyrosine Kinase AXL in Cancer Progression
por: Rankin, Erinn B., et al.
Publicado: (2016)

Specific Genomic Aberrations Predict Survival, But Low Mutation Rate in Cancer Hot Spots, in Clear Cell Renal Cell Carcinoma
por: Köhn, Linda, et al.
Publicado: (2015)

AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
por: Schmid, Edward T, et al.
Publicado: (2016)

Single Nucleotide Polymorphisms in the Wilms’ Tumour Gene 1 in Clear Cell Renal Cell Carcinoma
por: Li, Xingru, et al.
Publicado: (2013)

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
por: Evelönn, Emma Andersson, et al.
Publicado: (2019)

Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in  Clear - Cell Renal Cell Carcinoma (ccRCC)
por: Bielecka, Zofia F., et al.
Publicado: (2013)

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
por: Wu, Xinyan, et al.
Publicado: (2021)

Tensin3 Is a Negative Regulator of Cell Migration and All Four Tensin Family Members Are Downregulated in Human Kidney Cancer
por: Martuszewska, Danuta, et al.
Publicado: (2009)

Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor
por: Zhang, Hailiang, et al.
Publicado: (2023)

Alteration of Gene Expression Signatures of Cortical Differentiation and Wound Response in Lethal Clear Cell Renal Cell Carcinomas
por: Zhao, Hongjuan, et al.
Publicado: (2009)

AXL receptor tyrosine kinase as a therapeutic target in NSCLC
por: Okimoto, Ross A, et al.
Publicado: (2015)

Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression
por: He, Lirui, et al.
Publicado: (2020)

Axl receptor tyrosine kinase is a regulator of apolipoprotein E
por: Zhao, Wenchen, et al.
Publicado: (2020)

Predicting the Specificity- Determining Positions of Receptor Tyrosine Kinase Axl
por: Karakulak, Tülay, et al.
Publicado: (2021)

Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours
por: Green, J, et al.
Publicado: (2006)

Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells
por: Bansal, Nitu, et al.
Publicado: (2015)

Features of increased malignancy in eosinophilic clear cell renal cell carcinoma
por: Nilsson, Helén, et al.
Publicado: (2020)

Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
por: Thomasson, Marcus, et al.
Publicado: (2012)

Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas
por: Zhang, Qing, et al.
Publicado: (2019)

Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma
por: Sekino, Yohei, et al.
Publicado: (2022)

Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression
por: von Mässenhausen, Anne, et al.
Publicado: (2016)

AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis
por: Choi, Yun Jung, et al.
Publicado: (2019)

The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer
por: Uribe, Diana J., et al.
Publicado: (2017)

Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma
por: Andersson-Evelönn, Emma, et al.
Publicado: (2020)

Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation
por: Lauter, Markus, et al.
Publicado: (2019)

Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
por: Iida, Keisuke, et al.
Publicado: (2017)

Tumor tissue and plasma levels of AXL and GAS6 before and after tyrosine kinase inhibitor treatment in EGFR‐mutated non–small cell lung cancer
por: Nonagase, Yoshikane, et al.
Publicado: (2019)

Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma
por: Scherschinski, Lea, et al.
Publicado: (2022)

AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
por: Yan, Siyang, et al.
Publicado: (2019)

Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks
por: Wang, Yi, et al.
Publicado: (2021)

Interactions between TGF-β type I receptor and hypoxia-inducible factor-α mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma
por: Mallikarjuna, Pramod, et al.
Publicado: (2019)

Higher Expression of Receptor Tyrosine Kinase Axl, and Differential Expression of its Ligand, Gas6, Predict Poor Survival in Lung Adenocarcinoma Patients
por: Ishikawa, Masashi, et al.
Publicado: (2012)

The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung
por: Fujimori, T, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5d3pbncid6alt08u15i8nm5ou2